Safety of vedolizumab in the treatment of pregnant women with inflammatory bowel disease: a targeted literature review:

Background:Crohn’s disease (CD) and ulcerative colitis (UC) commonly affect women in their childbearing years. Vedolizumab (VDZ) is approved for treatment of moderate-to-severe CD and UC, but there...